EMPIL-DOC Act
Latest action (13 May 2020): Introduced
What this bill does
S. 3722, the EMPIL-DOC Act, would authorize $4 million per year for fiscal years 2021 through 2023 to the Secretary of Health and Human Services to fund a bilateral cooperative program with the government of Israel. The program would support grants for developing health technologies—such as artificial intelligence, sensors, monitoring devices, drugs and vaccines, respiratory assist devices, diagnostic tests, telemedicine, and remote monitoring—with a particular focus on using technology, personalized medicine, and data to address COVID-19. U.S. funding would be contingent on a matching financial contribution from Israel. The bill allows this funding to go either to an existing bilateral program or to a new one established after enactment, in consultation with the Secretary of State, under the framework of the 2008 U.S.-Israel science and technology cooperation agreement or a successor agreement.
The bill would primarily affect federal health funding priorities, U.S.-Israel scientific cooperation, and researchers or companies involved in relevant health technology development in both countries. It does not create new regulatory requirements for the public but establishes a funding mechanism for government-to-government collaboration.
The bill was introduced in the Senate on May 13, 2020, by Senator Ted Cruz along with several cosponsors, and was referred to the Senate Committee on Foreign Relations. As of the latest available information, it had not received a vote and did not advance further in the 116th Congress.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Expanding Medical Partnerships with Israel to Lessen Dependence on China Act or the EMPIL-DOC Act
This bill authorizes a bilateral grant program with Israel to develop health technologies, with an emphasis on the use of technology, personalized medicine, and data in relation to COVID-19 (i.e., coronavirus disease 2019). Technologies to be developed through this program include, among others, artificial intelligence, respiratory assist devices, and diagnostic tests.
In addition, the program conditions funding on a matching contribution from the government of Israel.
Common questions
- What does S. 3722 do?
- S. 3722, the EMPIL-DOC Act, would authorize $4 million per year for fiscal years 2021 through 2023 to the Secretary of Health and Human Services to fund a bilateral cooperative program with the government of Israel. The program would support grants for developing health technologies—such as artificial intelligence, sensors, monitoring devices, drugs and vaccines, respiratory assist devices, diagnostic tests, telemedicine, and remote monitoring—with a particular focus on using technology, personalized medicine, and data to address COVID-19. U.S. funding would be contingent on a matching financial contribution from Israel. The bill allows this funding to go either to an existing bilateral program or to a new one established after enactment, in consultation with the Secretary of State, under the framework of the 2008 U.S.-Israel science and technology cooperation agreement or a successor agreement. The bill would primarily affect federal health funding priorities, U.S.-Israel scientific cooperation, and researchers or companies involved in relevant health technology development in both countries. It does not create new regulatory requirements for the public but establishes a funding mechanism for government-to-government collaboration. The bill was introduced in the Senate on May 13, 2020, by Senator Ted Cruz along with several cosponsors, and was referred to the Senate Committee on Foreign Relations. As of the latest available information, it had not received a vote and did not advance further in the 116th Congress.
- Has S. 3722 become law?
- Not yet. As of 13 May 2020, S. 3722 is introduced.
- Who sponsored S. 3722?
- S. 3722 was sponsored by Sen. Ted Cruz [R-TX] (Republican-TX), with 40 cosponsors.
- What's the latest action on S. 3722?
- Introduced (13 May 2020).
Related bills in Health
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Wildland Firefighter Health and Safety Act
A resolution supporting the designation of October 2026 as “Substance Use & Misuse Prevention Month” to raise awareness of substance use and misuse in the United States.
Expressing support for the designation of the third week of September as “Fungal Disease Awareness Week” and encouraging efforts to improve awareness, diagnosis, treatment, surveillance, and prevention of fungal diseases in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.